These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29481373)

  • 1. Anticholinergic Medications and Cognitive Function in Late Midlife.
    Limback-Stokin MM; Krell-Roesch J; Roesler K; Hansen A; Stonnington CM; Temkit M; Caselli RJ; Geda YE
    Alzheimer Dis Assoc Disord; 2018; 32(3):262-264. PubMed ID: 29481373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment: A Cross-Sectional Analysis.
    Swami S; Cohen RA; Kairalla JA; Manini TM
    Drugs Aging; 2016 Nov; 33(11):809-818. PubMed ID: 27638818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia.
    Joshi YB; Thomas ML; Braff DL; Green MF; Gur RC; Gur RE; Nuechterlein KH; Stone WS; Greenwood TA; Lazzeroni LC; MacDonald LR; Molina JL; Nungaray JA; Radant AD; Silverman JM; Sprock J; Sugar CA; Tsuang DW; Tsuang MT; Turetsky BI; Swerdlow NR; Light GA
    Am J Psychiatry; 2021 Sep; 178(9):838-847. PubMed ID: 33985348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review.
    Andre L; Gallini A; Montastruc F; Montastruc JL; Piau A; Lapeyre-Mestre M; Gardette V
    Eur J Clin Pharmacol; 2019 Dec; 75(12):1631-1644. PubMed ID: 31468067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
    Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK
    J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study.
    Sittironnarit G; Ames D; Bush AI; Faux N; Flicker L; Foster J; Hilmer S; Lautenschlager NT; Maruff P; Masters CL; Martins RN; Rowe C; Szoeke C; Ellis KA;
    Dement Geriatr Cogn Disord; 2011; 31(3):173-8. PubMed ID: 21389718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study.
    Andre L; Gallini A; Montastruc F; Coley N; Montastruc JL; Vellas B; Andrieu S; Gardette V;
    Br J Clin Pharmacol; 2019 Jan; 85(1):71-99. PubMed ID: 30098049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticholinergic effect on cognition (AEC) of drugs commonly used in older people.
    Bishara D; Harwood D; Sauer J; Taylor DM
    Int J Geriatr Psychiatry; 2017 Jun; 32(6):650-656. PubMed ID: 27280553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AUGS Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder.
    This document was developed by the American Urogynecologic Society (AUGS) Guidelines Committee with the assistance of Tonya N. Thomas, MD, and Mark D. Walters, MD. This document reflects clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Its content is not intended to be a substitute for professional medical judgment, diagnosis, or treatment. The ultimate judgment regarding any specific procedure or treatment is to be made by the physician and patient in light of all circumstances presented by the patient.
    Female Pelvic Med Reconstr Surg; 2017; 23(3):177-178. PubMed ID: 28441276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.
    Green AR; Reifler LM; Boyd CM; Weffald LA; Bayliss EA
    Drugs Aging; 2018 Mar; 35(3):223-232. PubMed ID: 29404965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
    Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
    J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse Effects of Anticholinergic Drugs on Cognition and Mobility: Cutoff for Impairment in a Cross-Sectional Study in Young-Old and Old-Old Adults.
    Attoh-Mensah E; Loggia G; Schumann-Bard P; Morello R; Descatoire P; Marcelli C; Chavoix C
    Drugs Aging; 2020 Apr; 37(4):301-310. PubMed ID: 31930459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do cognitive and functional impairment relate to the use of anticholinergic medications in hospitalised patients aged 65 years and over?
    Kusljic S; Woolley A; Lowe M; Manias E
    Aging Clin Exp Res; 2020 Mar; 32(3):423-431. PubMed ID: 31124057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
    Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing cognitive effects of anticholinergic medications in patients with coronary artery disease.
    Lanctôt KL; O'Regan J; Schwartz Y; Swardfager W; Saleem M; Oh PI; Herrmann N
    Psychosomatics; 2014; 55(1):61-8. PubMed ID: 23993643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder.
    Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):69-71. PubMed ID: 33497068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atropinic (anticholinergic) burden in antipsychotic-treated patients.
    Montastruc F; Benevent J; Touafchia A; Chebane L; Araujo M; Guitton-Bondon E; Durrieu G; Arbus C; Schmitt L; Begaud B; Montastruc JL
    Fundam Clin Pharmacol; 2018 Feb; 32(1):114-119. PubMed ID: 28887902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care.
    Campbell NL; Lane KA; Gao S; Boustani MA; Unverzagt F
    Pharmacotherapy; 2018 May; 38(5):511-519. PubMed ID: 29600808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Ongoing Anticholinergic Burden Associated With Greater Cognitive Decline and Dementia Severity in Mild to Moderate Alzheimer's Disease?
    Dyer AH; Murphy C; Segurado R; Lawlor B; Kennelly SP;
    J Gerontol A Biol Sci Med Sci; 2020 Apr; 75(5):987-994. PubMed ID: 31613323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Anticholinergic Burden on Cognitive Performance: A Cohort Study of Community-Dwelling Older Adults.
    Nishtala PS; Allore H; Han L; Jamieson HA; Hilmer SN; Chyou TY
    J Am Med Dir Assoc; 2020 Sep; 21(9):1357-1358.e3. PubMed ID: 32402780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.